|
CN101372499A
|
|
Novel medicament having antiinflammatory activity
|
|
CN101353366A
|
|
Steroidal estrogen medicament for treating tumor
|
|
CN101353368A
|
|
Pregna medicament for treating tumor
|
|
CN101353369A
|
|
Preparation of 17 beta-spiro-1',2'-epoxyethane steride compound
|
|
CN101347621A
|
|
Medicament composition for treating respiratory disease
|
|
CN101347439A
|
|
Medicament for treating inflammatory bowel disease
|
|
CN101347438A
|
|
Medicament for slowing down angiogenesis of eye section
|
|
CN101347618A
|
|
Medicament composition for treating respiratory disease
|
|
CN101347619A
|
|
Medicament composition and use thereof in preparing medicament for treating inflammation of eye section
|
|
CN101199855A
|
|
Skinniness hormone packing matter water solution and application thereof
|
|
CN101190184A
|
|
Micronizing solid external application local anesthetic and preparation method thereof
|
|
CN101190887A
|
|
Synthesis of pharmaceutical
|
|
CN101190186A
|
|
22R-budesonide colon-targeted pellets and preparation method thereof
|
|
CN101117350A
|
|
Method for preparing steroids and novel intermediate compound used therein
|
|
CN1789237A
|
|
Method for synthesizing theanine
|
|
CN1594349A
|
|
Process for connecting side chain to androstane compound at 17th position
|
